Amperometric Bioplatforms To Detect Regional DNA Methylation with Single-Base Sensitivity

Area of Science:

• Biotechnology
• Biosensors
• Epigenetics

Background:

• 5-hydroxymethylcytosine (5-hmC) is a crucial epigenetic modification.
• Accurate detection of 5-hmC is vital for understanding gene regulation and disease, particularly cancer.
• Existing methods for 5-hmC detection often lack sensitivity or specificity.

Purpose of the Study:

• To develop and validate a novel electrochemical bioplatform for sensitive and specific detection of 5-hmC.
• To achieve single-base resolution for localized 5-hmC methylation analysis.
• To demonstrate the platform's utility in detecting 5-hmC in clinically relevant samples.

Main Methods:

• A bioplatform utilizing anti-5-hmC antibodies conjugated with horseradish peroxidase (HRP) bioreagents.
• Hybridization of target DNA to streptavidin-magnetic microbeads (Strep-MBs) with DNA capture probes.
• Electrochemical detection via amperometry at screen-printed carbon electrodes (SPCEs).
• Utilized commercial bioreagents ProtA-polyHRP₈₀ and Histostar for signal amplification.

Main Results:

• Achieved high sensitivity and single-nucleotide resolution for 5-hmC detection without DNA amplification.
• Demonstrated significant amplification factors (43.6-55.2) using novel bioreagents.
• Established low limits of detection (13.2-23.0 pM) for 5-hmC.
• Showcased excellent discrimination between 5-hmC and 5-methylcytosine (5-mC).
• Successfully detected regional 5-hmC in 10 ng of genomic DNA from colorectal cancer patient samples within 60 minutes.

Conclusions:

• The developed electrochemical bioplatform offers a sensitive, specific, and rapid method for 5-hmC detection.
• The platform enables localized and single-base resolution of 5-hmC methylation.
• This technology holds promise for epigenetic biomarker discovery and clinical diagnostics in cancer.